Clinical TrialsSearch results
Number of results: 819
Other
- LOGIK2004(NIke Study)
- Advanced non-small cell lung cancer
- Okamoto Isamu
- 2021-05-11
Other
- LOGIK2002(RESTART)
- Treatment-naive advanced non-squamous non-small cell lung cancer
- Okamoto Isamu
- 2021-02-25
Other
- LOGIK2001(SPEED)
- extensive disease small Cell Lung Cancer(ED-SCLC)
- Okamoto Isamu
- 2021-06-21
Other
- An Expanded Access trial in Japan to provide spesolimab to people with a flare-up in Generalized Pustular Psoriasis who have no other treatment options
- Generalized Pustular Psoriasis (GPP)
- Ohno Masashi
- 2022-02-23
Other
- Phase2 Study of Glivec (imatinib mesylate, formerly known as STI571) in Patients with Relapsed or Refractory Sarcomas with c-kit or PDGFR Expression
- Sarcoma with c-kit or PDGFR expression by immunohistochemistry
- Office of Imatinib phase2 study
- 2005-08-22
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31
Other
- Efficacy and safety of maintenance intravitreous injections of pegaptanib sodium every 6 weeks for 48 weeks in subjects with subfoveal neovascular Age-Related Macular Degeneration (AMD) initially treated with a modality resulting in maculopathy improvement: An exploratory study in a clinical setting
- Age-related macular degeneration
- NPO HEART
- 2009-03-31
Other
- A multicenter phaseII study of FOLFIRI as FOLFOX refractory second-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with honozygous for UGT1A1: (FLIGHT2)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-10
Other
- A multicenter phase II study of FOLFIRI as first-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with homozygous for UGT1A1(FLIGHT1)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-01
Completed
- A Study of TAK-994 in Adults with Narcolepsy
- Narcolepsy Type 1 (NT 1)
- Nonomura Hidenori
- 2021-04-28